Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Plos One|January 26, 2013
A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammationEvelien van der Meij, Giel G Koning, Patrick W Vriens, et al.
European Journal of Cancer (Oxford, England : 1990)|July 3, 2007
Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancerFrank J G M Kubben, Cornelis F M Sier, Lukas J A C Hawinkels, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 14, 2025
Fibrogenic Gene Signature as Early Prediction for the Efficacy of Pharmacological Interventions for MASH-Associated FibrosisJosé A Inia, Martine C Morrison, Arianne van Koppen, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 21, 2007
Endothelium specific matrilysin (MMP-7) expression in human cancersCornelis F M Sier, Lukas J A C Hawinkels, Henry J M A A Zijlmans, et al.
The Journal of Biological Chemistry|July 26, 2003
Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosisAnnemarie J van der Slot, Anne-Marie Zuurmond, Alfons F J Bardoel, et al.
Hepatology Communications|December 18, 2018
Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr-/-.Leiden MiceMartine C Morrison, Lars Verschuren, Kanita Salic, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 26, 2017
Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse ModelArianne van Koppen, Lars Verschuren, Anita M van den Hoek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2025
Prognostic Value of the TLM3 Biomarker Panel for Early Fibrosis Development in MASLD Within the General PopulationKoen C van Son, Jelle C B C de Jong, Serdar Özsezen, et al.
Nature Communications|May 29, 2024
Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLDLars Verschuren, Anne Linde Mak, Arianne van Koppen, et al.
Pageof 6